An early clinical trial evaluates a new RNA-based therapy to…

An early clinical trial evaluates a new RNA-based therapy to see whether it slows the progression of muscular dystrophy. The initial results show no meaningful therapeutic benefit, but later trials with larger groups reveal significant improvement. What type of error may have occurred?